Policy & Medicine – Page 33 – Legal, Regulatory, and Compliance Issues

QOL Medical and Their CEO Settle for $4.7 Million Over Alleged Kickback Scheme Involving Genetic Testing and Drug Claims

Vaccination at Risk: Tackling PBM Barriers to Ensure Equitable Access and Sustain Supply

Strengthening Mental Health Parity: New Rules Enhance Compliance and Network Adequacy Under MHPAEA

AMA Clarifies Role of BMI as a Measure in Medicine

Proposed Changes for the Mental Health Parity and Addiction Equity Act

ACCME Seeks Input on Delivering Accredited Education Through Online and Social Media Platforms

Bipartisan Legislation Introduced to Authorize PDTs in Medicare and Medicaid

PhRMA Submits Comments on 340B Program Stability

Bipartisan Legislation on Primary Care Announced — Bipartisan Primary Care and Health Workforce Act

Bipartisan Legislation Seeks to Update Rural Health Clinic Regulations – Rural Health Clinic Burden Reduction Act

10th Annual Mood Disorders Summit 2023 Covers MDD in Special Populations; Neuroplasticity in Mood Disorders; Psychedelics plus much more

Policy and Medicine Compliance Update September 2023 Issue Features: Research Data Sharing, SCOTUS SuperValu FCA Case, J&J Talic and what it means for Product Liability, False Certification and Kickback for EHR Companies

European CME: Recent Changes Made to the EACCME 3.0 Accreditation Criteria and Platform Restricting Satellite Symposium, Communication Companies and Event Sponsorships